BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pučić-Baković M, Zoldoš V, Fernandes D, Pemberton IK, Rudan I, Kennedy NA, Wuhrer M, Nimmo E, Annese V, McGovern DP, Satsangi J, Lauc G. The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 2014;11:588-600. [PMID: 24912389 DOI: 10.1038/nrgastro.2014.78] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Shubhakar A, Reiding KR, Gardner RA, Spencer DI, Fernandes DL, Wuhrer M. High-Throughput Analysis and Automation for Glycomics Studies. Chromatographia 2015;78:321-33. [PMID: 25814696 DOI: 10.1007/s10337-014-2803-9] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 9.4] [Reference Citation Analysis]
2 Sebastian A, Alzain MA, Asweto CO, Song H, Cui L, Yu X, Ge S, Dong H, Rao P, Wang H, Fang H, Gao Q, Zhang J, He D, Guo X, Song M, Wang Y, Wang W. Glycan Biomarkers for Rheumatoid Arthritis and Its Remission Status in Han Chinese Patients. OMICS 2016;20:343-51. [PMID: 27310476 DOI: 10.1089/omi.2016.0050] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
3 Miyoshi E, Shinzaki S, Fujii H, Iijima H, Kamada Y, Takehara T. Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease. Proteomics Clin Appl 2016;10:384-90. [PMID: 26427763 DOI: 10.1002/prca.201500089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
4 Castro-Dopico T, Clatworthy MR. IgG and Fcγ Receptors in Intestinal Immunity and Inflammation. Front Immunol 2019;10:805. [PMID: 31031776 DOI: 10.3389/fimmu.2019.00805] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
5 Chen Y, Yang B, Stanton C, Ross RP, Zhao J, Zhang H, Chen W. Bifidobacterium pseudocatenulatum Ameliorates DSS-Induced Colitis by Maintaining Intestinal Mechanical Barrier, Blocking Proinflammatory Cytokines, Inhibiting TLR4/NF-κB Signaling, and Altering Gut Microbiota. J Agric Food Chem 2021;69:1496-512. [DOI: 10.1021/acs.jafc.0c06329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Yan S, Yang B, Zhao J, Zhao J, Stanton C, Ross RP, Zhang H, Chen W. A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. Food Funct 2019;10:1595-608. [PMID: 30806428 DOI: 10.1039/c9fo00014c] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
7 Robinson AM, Gondalia SV, Karpe AV, Eri R, Beale DJ, Morrison PD, Palombo EA, Nurgali K. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016;22:2767-87. [DOI: 10.1097/mib.0000000000000970] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 5.6] [Reference Citation Analysis]
8 Huus KE, Petersen C, Finlay BB. Diversity and dynamism of IgA-microbiota interactions. Nat Rev Immunol 2021;21:514-25. [PMID: 33568782 DOI: 10.1038/s41577-021-00506-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
9 Štambuk T, Klasić M, Zoldoš V, Lauc G. N-glycans as functional effectors of genetic and epigenetic disease risk. Mol Aspects Med 2021;79:100891. [PMID: 32861467 DOI: 10.1016/j.mam.2020.100891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
10 Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol. 2020;17:597-617. [PMID: 32710014 DOI: 10.1038/s41575-020-0331-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
11 Campbell MP, Packer NH. UniCarbKB: New database features for integrating glycan structure abundance, compositional glycoproteomics data, and disease associations. Biochim Biophys Acta 2016;1860:1669-75. [PMID: 26940363 DOI: 10.1016/j.bbagen.2016.02.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
12 Zhang Y, Thanou M, Vllasaliu D. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. Eur J Pharm Biopharm 2020;155:128-38. [PMID: 32853696 DOI: 10.1016/j.ejpb.2020.08.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ijssennagger N, van Rooijen KS, Magnúsdóttir S, Ramos Pittol JM, Willemsen ECL, de Zoete MR, Baars MJD, Stege PB, Colliva C, Pellicciari R, Youssef SA, de Bruin A, Vercoulen Y, Kuipers F, van Mil SWC. Ablation of liver Fxr results in an increased colonic mucus barrier in mice. JHEP Rep 2021;3:100344. [PMID: 34604725 DOI: 10.1016/j.jhepr.2021.100344] [Reference Citation Analysis]
14 Liu J, Zhu Q, Han J, Zhang H, Li Y, Ma Y, He D, Gu J, Zhou X, Reveille JD, Jin L, Zou H, Ren S, Wang J. IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis. Mol Med 2019;25:25. [PMID: 31195969 DOI: 10.1186/s10020-019-0093-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
15 Elek Z, Kovács Z, Keszler G, Szabó M, Csanky E, Luo J, Guttman A, Rónai Z. High Throughput Multiplex SNP-analysis in Chronic Obstructive Pulmonary Disease and Lung Cancer. CMM 2020;20:185-93. [DOI: 10.2174/1566524019666191017123446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Allaire JM, Morampudi V, Crowley SM, Stahl M, Yu H, Bhullar K, Knodler LA, Bressler B, Jacobson K, Vallance BA. Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease. Am J Physiol Gastrointest Liver Physiol 2018;314:G360-77. [PMID: 29122749 DOI: 10.1152/ajpgi.00181.2017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
17 Gibold L, Garenaux E, Dalmasso G, Gallucci C, Cia D, Mottet-Auselo B, Faïs T, Darfeuille-Michaud A, Nguyen HT, Barnich N, Bonnet R, Delmas J. The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn's disease-associated Escherichia coli. Cell Microbiol 2016;18:617-31. [PMID: 26499863 DOI: 10.1111/cmi.12539] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
18 Chen Y, Jin Y, Stanton C, Paul Ross R, Zhao J, Zhang H, Yang B, Chen W. Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation. Eur J Nutr 2021;60:369-87. [PMID: 32350653 DOI: 10.1007/s00394-020-02252-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
19 Lim JS, Lim MY, Choi Y, Ko G. Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia. Mol Brain 2017;10:14. [PMID: 28427452 DOI: 10.1186/s13041-017-0292-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
20 Placet M, Molle CM, Arguin G, Geha S, Gendron FP. The expression of P2Y6 receptor promotes the quality of mucus in colitic mice. FEBS J 2021. [PMID: 33713543 DOI: 10.1111/febs.15819] [Reference Citation Analysis]
21 Fujii H, Shinzaki S, Iijima H, Wakamatsu K, Iwamoto C, Sobajima T, Kuwahara R, Hiyama S, Hayashi Y, Takamatsu S, Uozumi N, Kamada Y, Tsujii M, Taniguchi N, Takehara T, Miyoshi E. Core Fucosylation on T Cells, Required for Activation of T-Cell Receptor Signaling and Induction of Colitis in Mice, Is Increased in Patients With Inflammatory Bowel Disease. Gastroenterology 2016;150:1620-32. [DOI: 10.1053/j.gastro.2016.03.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
22 Gourdine JF, Brush MH, Vasilevsky NA, Shefchek K, Köhler S, Matentzoglu N, Munoz-Torres MC, McMurry JA, Zhang XA, Robinson PN, Haendel MA. Representing glycophenotypes: semantic unification of glycobiology resources for disease discovery. Database (Oxford) 2019;2019:baz114. [PMID: 31735951 DOI: 10.1093/database/baz114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Boros É, Prontvai B, Kellermayer Z, Balogh P, Sarlós P, Vincze Á, Varga C, Maróti Z, Bálint B, Nagy I. Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples. Biomolecules 2020;10:E974. [PMID: 32610492 DOI: 10.3390/biom10070974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Ruhaak LR. The Use of Multiple Reaction Monitoring on QQQ-MS for the Analysis of Protein- and Site-Specific Glycosylation Patterns in Serum. In: Lauc G, Wuhrer M, editors. High-Throughput Glycomics and Glycoproteomics. New York: Springer; 2017. pp. 63-82. [DOI: 10.1007/978-1-4939-6493-2_6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Morosi LG, Cutine AM, Cagnoni AJ, Manselle-Cocco MN, Croci DO, Merlo JP, Morales RM, May M, Pérez-Sáez JM, Girotti MR, Méndez-Huergo SP, Pucci B, Gil AH, Huernos SP, Docena GH, Sambuelli AM, Toscano MA, Rabinovich GA, Mariño KV. Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits. Sci Adv 2021;7:eabf8630. [PMID: 34144987 DOI: 10.1126/sciadv.abf8630] [Reference Citation Analysis]
26 Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol 2019;15:346-66. [PMID: 30858582 DOI: 10.1038/s41581-019-0129-4] [Cited by in Crossref: 287] [Cited by in F6Publishing: 263] [Article Influence: 287.0] [Reference Citation Analysis]
27 Satsangi J, Kitten O, Chavez M, Kalla R, Prel N, Meuwis MA, Scott S, Bonetti I, Ventham NT, Louis E. How to Apply for and Secure EU Funding for Collaborative IBD Research Projects. J Crohns Colitis 2016;10:363-70. [PMID: 26744440 DOI: 10.1093/ecco-jcc/jjv237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
28 Gouyer V, Dubuquoy L, Robbe-Masselot C, Neut C, Singer E, Plet S, Geboes K, Desreumaux P, Gottrand F, Desseyn JL. Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier. Sci Rep 2015;5:9577. [PMID: 25974250 DOI: 10.1038/srep09577] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
29 Yan S, Yang B, Ross RP, Stanton C, Zhang H, Zhao J, Chen W. Bifidobacterium longum subsp. longum YS108R fermented milk alleviates DSS induced colitis via anti-inflammation, mucosal barrier maintenance and gut microbiota modulation. Journal of Functional Foods 2020;73:104153. [DOI: 10.1016/j.jff.2020.104153] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
30 Ząbczyńska M, Link-Lenczowski P, Pocheć E. Glycosylation in Autoimmune Diseases. Adv Exp Med Biol 2021;1325:205-18. [PMID: 34495537 DOI: 10.1007/978-3-030-70115-4_10] [Reference Citation Analysis]
31 Chen F, Wen Q, Jiang J, Li HL, Tan YF, Li YH, Zeng NK. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs? J Ethnopharmacol 2016;179:253-64. [PMID: 26723469 DOI: 10.1016/j.jep.2015.12.031] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 12.3] [Reference Citation Analysis]
32 Kang J, Pisupati K, Benet A, Ruotolo BT, Schwendeman SP, Schwendeman A. Infliximab Biosimilars in the Age of Personalized Medicine. Trends Biotechnol 2018;36:987-92. [PMID: 29861288 DOI: 10.1016/j.tibtech.2018.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
33 Shubhakar A, Kozak RP, Reiding KR, Royle L, Spencer DI, Fernandes DL, Wuhrer M. Automated High-Throughput Permethylation for Glycosylation Analysis of Biologics Using MALDI-TOF-MS. Anal Chem 2016;88:8562-9. [PMID: 27479043 DOI: 10.1021/acs.analchem.6b01639] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 10.2] [Reference Citation Analysis]
34 Glade MJ, Meguid MM. A glance at … dietary emulsifiers, the human intestinal mucus and microbiome, and dietary fiber. Nutrition 2016;32:609-14. [PMID: 26899163 DOI: 10.1016/j.nut.2015.12.036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
35 Totten SM, Kullolli M, Pitteri SJ. Multi-Lectin Affinity Chromatography for Separation, Identification, and Quantitation of Intact Protein Glycoforms in Complex Biological Mixtures. Methods Mol Biol 2017;1550:99-113. [PMID: 28188526 DOI: 10.1007/978-1-4939-6747-6_9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
36 King SL, Joshi HJ, Schjoldager KT, Halim A, Madsen TD, Dziegiel MH, Woetmann A, Vakhrushev SY, Wandall HH. Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells. Blood Adv 2017;1:429-42. [PMID: 29296958 DOI: 10.1182/bloodadvances.2016002121] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 20.3] [Reference Citation Analysis]
37 Blandford LE, Johnston EL, Sanderson JD, Wade WG, Lax AJ. Promoter orientation of the immunomodulatory Bacteroides fragilis capsular polysaccharide A (PSA) is off in individuals with inflammatory bowel disease (IBD). Gut Microbes 2019;10:569-77. [PMID: 30732524 DOI: 10.1080/19490976.2018.1560755] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
38 Tailford LE, Crost EH, Kavanaugh D, Juge N. Mucin glycan foraging in the human gut microbiome. Front Genet 2015;6:81. [PMID: 25852737 DOI: 10.3389/fgene.2015.00081] [Cited by in Crossref: 354] [Cited by in F6Publishing: 312] [Article Influence: 59.0] [Reference Citation Analysis]
39 Xu Z, Zhang Y, Ocansey DKW, Wang B, Mao F. Glycosylation in Cervical Cancer: New Insights and Clinical Implications. Front Oncol 2021;11:706862. [PMID: 34485140 DOI: 10.3389/fonc.2021.706862] [Reference Citation Analysis]
40 Etienne-mesmin L, Chassaing B, Desvaux M, De paepe K, Gresse R, Sauvaitre T, Forano E, de Wiele TV, Schüller S, Juge N, Blanquet-diot S. Experimental models to study intestinal microbes–mucus interactions in health and disease. FEMS Microbiology Reviews 2019;43:457-89. [DOI: 10.1093/femsre/fuz013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
41 Theodoratou E, Thaçi K, Agakov F, Timofeeva MN, Štambuk J, Pučić-Baković M, Vučković F, Orchard P, Agakova A, Din FV, Brown E, Rudd PM, Farrington SM, Dunlop MG, Campbell H, Lauc G. Glycosylation of plasma IgG in colorectal cancer prognosis. Sci Rep 2016;6:28098. [PMID: 27302279 DOI: 10.1038/srep28098] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
42 Dierckx T, Verstockt B, Vermeire S, van Weyenbergh J. GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD. J Crohns Colitis. 2019;13:389-394. [PMID: 30312386 DOI: 10.1093/ecco-jcc/jjy162] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
43 Prenc E, Pulanic D, Pucic-Bakovic M, Pezer M, Desnica L, Vrhovac R, Nemet D, Pavletic SZ. Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation. Biochim Biophys Acta 2016;1860:1615-22. [PMID: 26923767 DOI: 10.1016/j.bbagen.2016.02.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
44 Tarris G, de Rougemont A, Estienney M, Charkaoui M, Mouillot T, Bonnotte B, Michiels C, Martin L, Belliot G. Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease. mSphere 2021;6:e01185-20. [PMID: 33441404 DOI: 10.1128/mSphere.01185-20] [Reference Citation Analysis]
45 Iwatani S, Shinzaki S, Amano T, Otake Y, Tani M, Yoshihara T, Tsujii Y, Hayashi Y, Inoue T, Okuzaki D, Mizushima T, Miyoshi E, Iijima H, Takehara T. Oligosaccharide‐dependent anti‐inflammatory role of galectin‐1 for macrophages in ulcerative colitis. Journal of Gastroenterology and Hepatology 2020;35:2158-69. [DOI: 10.1111/jgh.15097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Ditzler G, Morrison JC, Lan Y, Rosen GL. Fizzy: feature subset selection for metagenomics. BMC Bioinformatics 2015;16:358. [PMID: 26538306 DOI: 10.1186/s12859-015-0793-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
47 Dall'Olio F, Malagolini N. Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions. Exp Suppl 2021;112:303-40. [PMID: 34687015 DOI: 10.1007/978-3-030-76912-3_10] [Reference Citation Analysis]
48 Mu Z, Yang Y, Xia Y, Wang F, Sun Y, Yang Y, Ai L. Probiotic yeast BR14 ameliorates DSS-induced colitis by restoring the gut barrier and adjusting the intestinal microbiota. Food Funct 2021. [PMID: 34355721 DOI: 10.1039/d1fo01314a] [Reference Citation Analysis]
49 Wang J, Huang C, Zhou J, Zhao K, Li Y. Causal link between immunoglobulin G glycosylation and cancer: A potential glycobiomarker for early tumor detection. Cell Immunol 2021;361:104282. [PMID: 33453507 DOI: 10.1016/j.cellimm.2021.104282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Wang H, Li X, Wang X, Liu D, Zhang X, Cao W, Zheng Y, Guo Z, Li D, Xing W, Hou H, Wu L, Song M, Zhong Z, Wang Y, Tan X, Lauc G, Wang W. Next-Generation (Glycomic) Biomarkers for Cardiometabolic Health: A Community-Based Study of Immunoglobulin G N-Glycans in a Chinese Han Population. OMICS 2019;23:649-59. [PMID: 31313980 DOI: 10.1089/omi.2019.0099] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
51 Wang T, Hoi KM, Stöckmann H, Wan C, Sim LC, Shi Jie Tay NHBK, Poo CH, Woen S, Yang Y, Zhang P, Rudd PM. LC/MS-based Intact IgG and Released Glycan Analysis for Bioprocessing Applications. Biotechnol J 2018;13:e1700185. [PMID: 29341427 DOI: 10.1002/biot.201700185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
52 Corfield AP. The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human. Microorganisms 2018;6:E78. [PMID: 30072673 DOI: 10.3390/microorganisms6030078] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 18.7] [Reference Citation Analysis]
53 Ding M, Guan Z, Cai H, Huang Y, Lin Y, Hu X. Reductive oxyamination: a method for the qualitative and quantitative analysis of monosaccharides with a new aminooxy reagent using high-performance liquid chromatography with fluorescence detection. Anal Bioanal Chem 2018;410:79-89. [PMID: 29071364 DOI: 10.1007/s00216-017-0693-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Vindigni SM, Zisman TL, Suskind DL, Damman CJ. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol. 2016;9:606-625. [PMID: 27366227 DOI: 10.1177/1756283x16644242] [Cited by in Crossref: 89] [Cited by in F6Publishing: 57] [Article Influence: 17.8] [Reference Citation Analysis]
55 Aviello G, Knaus UG. NADPH oxidases and ROS signaling in the gastrointestinal tract. Mucosal Immunol 2018;11:1011-23. [DOI: 10.1038/s41385-018-0021-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 21.7] [Reference Citation Analysis]
56 Corfield A. Eukaryotic protein glycosylation: a primer for histochemists and cell biologists. Histochem Cell Biol 2017;147:119-47. [PMID: 28012131 DOI: 10.1007/s00418-016-1526-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 15.6] [Reference Citation Analysis]
57 Trbojević Akmačić I, Ventham NT, Theodoratou E, Vučković F, Kennedy NA, Krištić J, Nimmo ER, Kalla R, Drummond H, Štambuk J, Dunlop MG, Novokmet M, Aulchenko Y, Gornik O, Campbell H, Pučić Baković M, Satsangi J, Lauc G; IBD-BIOM Consortium. Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm Bowel Dis 2015;21:1237-47. [PMID: 25895110 DOI: 10.1097/MIB.0000000000000372] [Cited by in Crossref: 38] [Cited by in F6Publishing: 66] [Article Influence: 7.6] [Reference Citation Analysis]
58 Vanderschaeghe D, Meuris L, Raes T, Grootaert H, Van Hecke A, Verhelst X, Van de Velde F, Lapauw B, Van Vlierberghe H, Callewaert N. Endoglycosidase S Enables a Highly Simplified Clinical Chemistry Procedure for Direct Assessment of Serum IgG Undergalactosylation in Chronic Inflammatory Disease. Mol Cell Proteomics 2018;17:2508-17. [PMID: 30190373 DOI: 10.1074/mcp.TIR118.000740] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
59 Castro-Dopico T, Clatworthy MR. Mucosal IgG in inflammatory bowel disease - a question of (sub)class? Gut Microbes 2020;12:1-9. [PMID: 31480888 DOI: 10.1080/19490976.2019.1651596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Shinzaki S, Ishii M, Fujii H, Iijima H, Wakamatsu K, Kawai S, Shiraishi E, Hiyama S, Inoue T, Hayashi Y, Kuwahara R, Takamatsu S, Kamada Y, Morii E, Tsujii M, Takehara T, Miyoshi E. N-Acetylglucosaminyltransferase V exacerbates murine colitis with macrophage dysfunction and enhances colitic tumorigenesis. J Gastroenterol 2016;51:357-69. [PMID: 26349931 DOI: 10.1007/s00535-015-1119-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
61 Yang B, Gao H, Qi H, Chen Y, Ross RP, Stanton C, Zhao J, Zhang H, Chen H, Chen W. Linoleate Isomerase Complex Contributes to Metabolism and Remission of DSS-Induced Colitis in Mice of Lactobacillus plantarum ZS2058. J Agric Food Chem 2021;69:8160-71. [PMID: 34281339 DOI: 10.1021/acs.jafc.1c02944] [Reference Citation Analysis]
62 Saku A, Suehiro K, Nakamura K, Nishimura N, Yokota M, Hirose K, Nakajima H. Mice lacking fucosyltransferase 2 show reduced innate allergic inflammation in the airways. Allergy 2020;75:1253-6. [DOI: 10.1111/all.14101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Shon DJ, Kuo A, Ferracane MJ, Malaker SA. Classification, structural biology, and applications of mucin domain-targeting proteases. Biochemical Journal 2021;478:1585-603. [DOI: 10.1042/bcj20200607] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
64 Stylianou E. Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics. Mol Diagn Ther 2018;22:11-23. [DOI: 10.1007/s40291-017-0298-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
65 Castro-Dopico T, Colombel JF, Mehandru S. Targeting B cells for inflammatory bowel disease treatment: back to the future. Curr Opin Pharmacol 2020;55:90-8. [PMID: 33166872 DOI: 10.1016/j.coph.2020.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
66 Hinneburg H, Korać P, Schirmeister F, Gasparov S, Seeberger PH, Zoldoš V, Kolarich D. Unlocking Cancer Glycomes from Histopathological Formalin-fixed and Paraffin-embedded (FFPE) Tissue Microdissections. Mol Cell Proteomics 2017;16:524-36. [PMID: 28122943 DOI: 10.1074/mcp.M116.062414] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 6.8] [Reference Citation Analysis]
67 Holmberg FE, Pedersen J, Jørgensen P, Soendergaard C, Jensen KB, Nielsen OH. Intestinal barrier integrity and inflammatory bowel disease: Stem cell‐based approaches to regenerate the barrier. J Tissue Eng Regen Med 2018;12:923-35. [DOI: 10.1002/term.2506] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
68 Alves I, Vicente MM, Dias AM, Gaifem J, Rodrigues C, Campar A, Pinho SS. The Role of Glycosylation in Inflammatory Diseases. Adv Exp Med Biol 2021;1325:265-83. [PMID: 34495540 DOI: 10.1007/978-3-030-70115-4_13] [Reference Citation Analysis]
69 Chen Y, Jin Y, Stanton C, Ross RP, Wang Z, Zhao J, Zhang H, Yang B, Chen W. Dose-response efficacy and mechanisms of orally administered CLA-producing Bifidobacterium breve CCFM683 on DSS-induced colitis in mice. Journal of Functional Foods 2020;75:104245. [DOI: 10.1016/j.jff.2020.104245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Ventham NT, Kalla R, Kennedy NA, Satsangi J, Arnott ID. Predicting outcomes in acute severe ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2015;9:405-415. [PMID: 25494666 DOI: 10.1586/17474124.2015.992880] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
71 Juge N, Tailford L, Owen CD. Sialidases from gut bacteria: a mini-review. Biochem Soc Trans 2016;44:166-75. [PMID: 26862202 DOI: 10.1042/BST20150226] [Cited by in F6Publishing: 41] [Reference Citation Analysis]
72 Seeling M, Brückner C, Nimmerjahn F. Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity? Nat Rev Rheumatol 2017;13:621-30. [DOI: 10.1038/nrrheum.2017.146] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 17.8] [Reference Citation Analysis]
73 Klasić M, Markulin D, Vojta A, Samaržija I, Biruš I, Dobrinić P, Ventham NT, Trbojević-Akmačić I, Šimurina M, Štambuk J, Razdorov G, Kennedy NA, Satsangi J, Dias AM, Pinho S, Annese V, Latiano A, D'Inca R, Lauc G, Zoldoš V; IBD consortium. Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease. Clin Epigenetics 2018;10:75. [PMID: 29991969 DOI: 10.1186/s13148-018-0507-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
74 Clerc F, Novokmet M, Dotz V, Reiding KR, de Haan N, Kammeijer GSM, Dalebout H, Bladergroen MR, Vukovic F, Rapp E, Targan SR, Barron G, Manetti N, Latiano A, McGovern DPB, Annese V, Lauc G, Wuhrer M; IBD-BIOM Consortium. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases. Gastroenterology 2018;155:829-43. [PMID: 29792883 DOI: 10.1053/j.gastro.2018.05.030] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 12.7] [Reference Citation Analysis]
75 Kiryluk K, Li Y, Moldoveanu Z, Suzuki H, Reily C, Hou P, Xie J, Mladkova N, Prakash S, Fischman C, Shapiro S, LeDesma RA, Bradbury D, Ionita-Laza I, Eitner F, Rauen T, Maillard N, Berthoux F, Floege J, Chen N, Zhang H, Scolari F, Wyatt RJ, Julian BA, Gharavi AG, Novak J. GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway. PLoS Genet 2017;13:e1006609. [PMID: 28187132 DOI: 10.1371/journal.pgen.1006609] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]
76 Sun X, Zhan M, Sun X, Liu W, Meng X. C1GALT1 in health and disease. Oncol Lett 2021;22:589. [PMID: 34149900 DOI: 10.3892/ol.2021.12850] [Reference Citation Analysis]
77 Gutiérrez A, Miller I, Kolarich D, Hummel K, Nöbauer K, Razzazi-fazeli E. Detection and first characterization of an uncommon haptoglobin in porcine saliva of pigs with rectal prolapse by using boronic acid sample enrichment. Animal 2017;11:845-53. [DOI: 10.1017/s1751731116002159] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
78 Zhou X, Kailemia MJ, Sun Y, Shuai Z, Yang GX, Dhaliwal S, Cristoferi L, Leung PSC, Invernizzi P, Bowlus CL, Lebrilla CB, Ansari AA, Ridgway WM, Zhang W, Gershwin ME. Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis. J Autoimmun 2020;113:102503. [PMID: 32546343 DOI: 10.1016/j.jaut.2020.102503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
79 Renouf MJ, Cho YH, McPhee JB. Emergent Behavior of IBD-Associated Escherichia coli During Disease. Inflamm Bowel Dis 2019;25:33-44. [PMID: 30321333 DOI: 10.1093/ibd/izy312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
80 Suhre K, McCarthy MI, Schwenk JM. Genetics meets proteomics: perspectives for large population-based studies. Nat Rev Genet 2021;22:19-37. [PMID: 32860016 DOI: 10.1038/s41576-020-0268-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
81 Earley H, Lennon G, Balfe Á, Coffey JC, Winter DC, O'Connell PR. The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis. Sci Rep 2019;9:15683. [PMID: 31666581 DOI: 10.1038/s41598-019-51878-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 21.5] [Reference Citation Analysis]